Literature DB >> 16750982

The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test result.

Donald W Cockcroft1, Beth E Davis.   

Abstract

Methacholine tests are widely used as a diagnostic aid for asthma. Their strength has been reputed to be the high sensitivity and very infrequent occurrence of false-negative test results (ie, high negative predictive value). There are 2 commonly used methods that have been outlined by the American Thoracic Society. These methods were thought to give equivalent results. However, in 3 investigations in which we have compared the 2 methods, we have demonstrated a marked lack of comparability. In subjects with borderline to mild airway responsiveness (tidal breathing, methacholine PC20 >2 mg/mL), the 5 deep inhalations required of the dosimeter method produce marked bronchoprotection in some subjects with asthma. The result of this bronchoprotection is that in 55 subjects with asthma, 50% of those whose tidal breathing PC20 value was greater than 2 mg/mL and 25% of the total had negative methacholine challenge results. This indicates that the standardized dosimeter method has an unacceptable loss of diagnostic sensitivity. We recommend that the dosimeter method not be performed as outlined by the American Thoracic Society and that methacholine should be administered by means of submaximal inhalations or tidal breathing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750982     DOI: 10.1016/j.jaci.2006.02.038

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

Review 1.  Diagnostic and therapeutic value of airway challenges in asthma.

Authors:  Donald W Cockcroft; Beth E Davis
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

2.  Bronchoprovocation testing.

Authors:  Chakravarthy Reddy
Journal:  Clin Rev Allergy Immunol       Date:  2009-03-17       Impact factor: 8.667

3.  Different cutoff values of methacholine bronchial provocation test depending on age in children with asthma.

Authors:  Eun Lee; Young-Ho Kim; Seungbong Han; Song-I Yang; Young-Ho Jung; Ju-Hee Seo; Hyo-Bin Kim; So Yeon Lee; Ji-Won Kwon; Soo-Jong Hong
Journal:  World J Pediatr       Date:  2017-03-08       Impact factor: 2.764

4.  Methacholine challenge as a clinical bioassay of pulmonary delivery of a long-acting β₂-adrenergic agonist.

Authors:  Sreekala Prabhakaran; Jonathan Shuster; Richard Ahrens; Leslie Hendeles
Journal:  Pharmacotherapy       Date:  2011-05       Impact factor: 4.705

5.  Negative methacholine challenge tests in subjects who report physician-diagnosed asthma.

Authors:  K W McGrath; J V Fahy
Journal:  Clin Exp Allergy       Date:  2010-11-24       Impact factor: 5.018

6.  Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16.

Authors:  Kathryn Blake; James D Cury; Jobayer Hossain; Kelan Tantisira; Jianwei Wang; Edward Mougey; John Lima
Journal:  Pulm Pharmacol Ther       Date:  2013-02-04       Impact factor: 3.410

7.  Relationship between the baseline alveolar volume-to-total lung capacity ratio and airway responsiveness.

Authors:  David A Kaminsky; Anees Daud; David G Chapman
Journal:  Respirology       Date:  2014-07-03       Impact factor: 6.424

8.  Assessment of airway hyperreactivity: comparison of forced spirometry and body plethysmography for methacholine challenge tests.

Authors:  F Nensa; W Marek; E Marek; H-J Smith; M Kohlhäufl
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

9.  Airway resistance at maximum inhalation as a marker of asthma and airway hyperresponsiveness.

Authors:  Nancy T Mendonça; Jennifer Kenyon; Adam S LaPrad; Sohera N Syeda; George T O'Connor; Kenneth R Lutchen
Journal:  Respir Res       Date:  2011-07-15

10.  Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma.

Authors:  Sandra D Anderson; Brett Charlton; John M Weiler; Sara Nichols; Sheldon L Spector; David S Pearlman
Journal:  Respir Res       Date:  2009-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.